This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Mendez, D. Articles by Sánchez de la Cuesta, F. Search for Related Content PubMed PubMed Citation Articles by Mendez, D. Articles by Sánchez de la Cuesta, F. Related Collections Pharmacology

---

ANESTHETIC PHARMACOLOGY

The Effect of Propofol on the Interaction of Platelets with Leukocytes and Erythrocytes in Surgical Patients

D. Mendez, PhD^*, J.P. De La Cruz, PhD, M.M. Arrebola, PhD, A. Guerrero, PhD, J.A. González-Correa, PhD, E. García-Temboury, MD^*, and F. Sánchez de la Cuesta, PhD

*Anesthesiology and Resuscitation Unit, Carlos Haya University Hospital, Málaga; and Department of Pharmacology and Therapeutics, School of Medicine, University of Málaga, Spain

Address correspondence and reprint requests to J.P. De La Cruz, PhD, Department of Pharmacology and Therapeutics, School of Medicine, University of Málaga, 29071 Málaga, Spain. Address e-mail to jpcruz{at}uma.es

We tested the antiplatelet effect described for propofol in vitro in surgical patients. Platelet aggregation induced by adenosine diphosphate, collagen, and arachidonic acid was tested in samples of whole blood, platelet-rich plasma (PRP), PRP with red blood cells, and PRP with leukocytes. Also measured were platelet production of thromboxane (Tx)B₂ and leukocyte production of 6-keto-prostaglandin F₁ (a stable metabolite of prostacyclin) and plasma levels of nitrites + nitrates (indicator of nitric oxide production). Anesthesia was induced with a bolus IV injection of sodium thiopental 4 mg/kg (n = 10), with a bolus dose of 2.5 mg/kg of propofol (n = 20), or with propofol total IV anesthesia (n = 20). Sodium thiopental did not modify any of the analytical values. In patients who received a bolus injection of propofol, platelet aggregation was significantly reduced in whole blood and in PRP + leukocytes. Platelet production of TxB₂ was reduced by 35%; the inhibition of 6-keto-prostaglandin F₁ was not statistically significant. Plasma levels of nitrites + nitrates increased by 37%; this change correlated significantly with the decrease in systolic and diastolic blood pressure (both P < 0.05). Similar changes, albeit of larger magnitude, were seen in patients who were given total IV anesthesia with propofol. In conclusion, propofol inhibited platelet aggregation in surgical patients mainly as a result of the inhibition of Tx synthesis and the increase in nitric oxide production. These effects are thought to be related to the hypotensive effect of this anesthetic.

IMPLICATIONS: In vitro experiments have shown that propofol inhibits platelet aggregation and increases nitric oxide production. This study shows that doses habitually used to induce or maintain anesthesia also have these effects. These findings have potential applications for patients at increased risk for bleeding and may partly explain the hypotensive effect of propofol.

This article has been cited by other articles:

				A. M. Dyszkiewicz-Korpanty, E. P. Frenkel, and R. Sarode Approach to the Assessment of Platelet Function: Comparison between Optical-based Platelet-rich Plasma and Impedance-based Whole Blood Platelet Aggregation Methods Clinical and Applied Thrombosis/Hemostasis, January 1, 2005; 11(1): 25 - 35. [Abstract] [PDF]